Overview of Dr. Brohl
Dr. Andrew Brohl is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 11 years. Dr. Brohl accepts several types of health insurance, listed below. He is one of 172 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 70 publications and over 500 citings.
Office
10920 McKinley Dr
Tampa, FL 33612Fax+1 813-745-8337- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2006 - 2009
University of Miami Leonard M. Miller School of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2015 - 2025
NY State Medical License 2013 - 2017
VA State Medical License 2006 - 2014
DC State Medical License 2006 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients Start of enrollment: 2020 Dec 22
- IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients Start of enrollment: 2020 Sep 24
- Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma Start of enrollment: 2021 May 24
- Join now to see all
Publications & Presentations
PubMed
- First-in-human stage III/IV melanoma clinical trial of immune priming agent IFx-Hu2.0.Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edw...> ;Molecular Cancer Therapeutics. 2024 Apr 24
- Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.Baginska, J., Nau, A., Gomez Diaz, I., Giobbie-Hurder, A., Weirather, J., Vergara, J., Abrecht, C., Hallisey, M., Dennis, J., Severgnini, M., Huezo, J., Marciello, I.,...> ;Cancer Immunology, Immunotherapy. 2024 Jan 18
- 1 citationsC19MC miRNA-520G inducesantiviral gene transcription and inhibits melanin production in skin cutaneous melanoma.Goodwin G Jinesh, Marian T Smallin, Nino Mtchedlidze, Isha Godwin, Marco Napoli, Nicole Hackel, Manali S Phadke, Avani A Deshpande, Xiaobo Li, John H Lockhart, Jaden R...> ;Genes & Diseases. 2024 Jan 1
- Join now to see all
Journal Articles
- Identification of a Novel MTAP-RAF1 Fusion in a Soft Tissue SarcomaAndrew Brohl, MD, BioMed Central
Press Mentions
Tampa-Based Morphogenesis Seeks Skin Cancer Patients for New Clinical TrialsJune 16th, 2020
Genomic Landscape of Merkel Cell CarcinomaAugust 23rd, 2019
Moffitt Researchers Complete Largest Genomic Analysis of Merkel Cell Carcinoma PatientsAugust 20th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem KeyCare PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Multiplan PHCS PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
